SCHEMBL10014404

SCHEMBL10014404

CC(=O)CSC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11805574 0.91 CYP2C19 (0.37)
SCHEMBL11805596 0.89 CYP2C19 (0.36)
SCHEMBL2112190 0.80 CYP2C19 (0.42)
SCHEMBL8340216 0.80
SCHEMBL426229 0.78
SCHEMBL8963639 0.75
SCHEMBL7088538 0.75
SCHEMBL14041166 0.75
SCHEMBL9197945 0.75
SCHEMBL1275144 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109762117-A The synthetic method of polyether polyol 山东蓝星东大有限公司 2019-05-17 CN claimed
CN-109762117-A The synthetic method of polyether polyol 山东蓝星东大有限公司 2019-05-17 CN disclosed
US-9598466-B2 Glycopeptide constructs and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2017-03-21 US disclosed
US-20120039843-A1 CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE N.V. ORGANON (NL) 2012-02-16 US disclosed
US-8106007-B2 Having affinity to antithrombin III; improved pharmacokinetic properties when compared to the original polypeptides N.V. ORGANON (NL) 2012-01-31 US disclosed
US-20110229510-A1 GLYCOPEPTIDE CONSTRUCTS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2011-09-22 US disclosed
US-7910088-B2 Multivalent constructs for therapeutic and diagnostic applications BRACCO SUISSE SA (CH) 2011-03-22 US disclosed
US-7807136-B2 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer Rose, David S. (US) 2010-10-05 US disclosed
US-20100062006-A9 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer MAYERS GEORGE L 2010-03-11 US disclosed
US-7459429-B2 Method of treating disturbances of iron distribution in inflammatory intestinal diseases HOFFMANN-LA ROCHE INC. (US) 2008-12-02 US disclosed
US-20080139459-A1 Conjugates A Polypeptide And A Pentasaccharide N.V. ORGANON (NL) 2008-06-12 US disclosed
US-20070106064-A1 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same DEVELOPMENT CENTER FOR BIOTECHNOLOGY 2007-05-10 US disclosed
US-20070106064-A1 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same DEVELOPMENT CENTER FOR BIOTECHNOLOGY 2007-05-10 US disclosed
CN-1073451-A Latent thiol amine-thiol chain transfer agents and the application in polymkeric substance is synthetic thereof ROHM & HAAS (US) 1993-06-23 CN disclosed
US-4473391-A Herbicides containing thiazolo[2,3-b]quinazolones as active ingredients, and their use for regulating plant growth BASF AKTIENGESELLSCHAFT (DE) 1984-09-25 US disclosed
US-4338435-A Benzothiadiazines having diuretic activity E. R. SQUIBB & SONS, INC. (US) 1982-07-06 US disclosed
US-4052545-A PROCESS FOR POLYMERIZING CONJUGATED DIENES THE FIRESTONE TIRE & RUBBER COMPANY (US) 1977-10-04 US disclosed
US-3948869-A Process for polymerizing conjugated dienes THE FIRESTONE TIRE & RUBBER COMPANY (US) 1976-04-06 US disclosed